title: Liver Transplantation in India: At the Crossroads.
abstract: As the liver transplant journey in India reaches substantial numbers and suggests quality technical expertise, it is time to dispassionately look at the big picture, identify problems, and consider corrective measures for the future. Several features characterize the current scenario. Although the proportion of deceased donor liver transplants is increasing, besides major regional imbalances, the activity is heavily loaded in favor of the private sector and live donor transplants. The high costs of the procedure, the poor participation of public hospitals, the lack of a national registry, and outcomes reporting are issues of concern. Organ sharing protocols currently based on chronology or institutional rotation need to move to a more justiciable severity-based system. Several measures can expand the deceased donor pool. The safety of the living donor continues to need close scrutiny and focus. Multiple medical challenges unique to the Indian situation are also being thrown up. Although many of the deficits demand state intervention and policy changes the transplant community needs to take notice and highlight them. The future of liver transplantation in India should move toward a more accountable, equitable, and accessible form. We owe this to our citizens who have shown tremendous faith in us by volunteering to be living donors as well as consenting for deceased donation.
authors.affiliation: Department of Surgical Gastroenterology, Jaslok Hospital and Research Centre, India.
authors.forename: Sanjay
authors.initials: S
authors.lastname: Nagral
authors.affiliation: Department of General Surgery, K.B. Bhabha Municipal General Hospital, India.
authors.forename: Aditya
authors.initials: A
authors.lastname: Nanavati
authors.affiliation: Department of Gastroenterology, Jaslok Hospital and Research Centre, India.
authors.forename: Aabha
authors.initials: A
authors.lastname: Nagral
keywords: ALF, acute liver failure; CMV, cytomegalovirus; CT, computerized tomography; DBD, donation after brain death; DCD, donation after cardiac death; DDLT, deceased donor liver transplant; DNA, deoxyribonucleic acid; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HOTA, Human Organs Transplant Act; ICU, intensive care unit; INASL, Indian Association for Study of the Liver; ISOT, Indian Society of Organ Transplantation; India; KCH, King's College Hospital; LDLT, live donor liver transplantation; LT, liver transplantation; MELD, model for end stage liver disease; NASH, non-alcoholic steatohepatitis; NGO, non-governmental organizations; NOTTO, National Organ and Tissue Transplant Organization; NTORC, non transplant organ retrieval center; OPTN, Organ Procurement Transplant Network; RGJAY, Rajiv Gandhi JeevandayeeArogyaYojana; ROTTO, Regional Organ and Tissue Transplant Organization; SOTTO, State Organ and Tissue Transplant Organization; SRTR, Scientific Registry of Transplant Recipients; TB, tuberculosis; UCSF, University of California San Francisco; UK, United Kingdom; UKELD, United Kingdom End stage Liver Disease; UKNHSBT, UK the National Health Services Blood and Transplant Authority; UNOS, United Network for Organ Sharing; USA, United States of America; ZTCC, Zonal Transplant Coordination Centre; donation after brain death; liver transplantation; living donor liver transplant